Mrsny RJ - Search Results

1

Intestinal permeation enhancers for oral peptide delivery.

Maher S, Mrsny RJ, Brayden DJ. Maher S, et al. Among authors: mrsny rj. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):277-319. doi: 10.1016/j.addr.2016.06.005. Epub 2016 Jun 16. Adv Drug Deliv Rev. 2016. PMID: 27320643 Review.

2

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.

Brayden DJ, Hill TA, Fairlie DP, Maher S, Mrsny RJ. Brayden DJ, et al. Among authors: mrsny rj. Adv Drug Deliv Rev. 2020;157:2-36. doi: 10.1016/j.addr.2020.05.007. Epub 2020 May 29. Adv Drug Deliv Rev. 2020. PMID: 32479930 Free article. Review.

3

Oral peptide delivery: prioritizing the leading technologies.

Brayden DJ, Mrsny RJ. Brayden DJ, et al. Among authors: mrsny rj. Ther Deliv. 2011 Dec;2(12):1567-73. doi: 10.4155/tde.11.114. Ther Deliv. 2011. PMID: 22833982 Free article. No abstract available.

4

Introduction for the special issue on recent advances in drug delivery across tissue barriers.

Mrsny RJ, Brayden DJ. Mrsny RJ, et al. Tissue Barriers. 2016 Jun 7;4(2):e1187981. doi: 10.1080/21688370.2016.1187981. eCollection 2016 Apr-Jun. Tissue Barriers. 2016. PMID: 27358759 Free PMC article.

5

Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.

Feighery LM, Cochrane SW, Quinn T, Baird AW, O'Toole D, Owens SE, O'Donoghue D, Mrsny RJ, Brayden DJ. Feighery LM, et al. Among authors: mrsny rj. Pharm Res. 2008 Jun;25(6):1377-86. doi: 10.1007/s11095-007-9527-6. Pharm Res. 2008. PMID: 18163202

6

Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease.

Siccardi D, Turner JR, Mrsny RJ. Siccardi D, et al. Among authors: mrsny rj. Adv Drug Deliv Rev. 2005 Jan 6;57(2):219-35. doi: 10.1016/j.addr.2004.08.005. Adv Drug Deliv Rev. 2005. PMID: 15555739 Review.

7

Lessons from nature: "Pathogen-Mimetic" systems for mucosal nano-medicines.

Mrsny RJ. Mrsny RJ. Adv Drug Deliv Rev. 2009 Feb 27;61(2):172-92. doi: 10.1016/j.addr.2008.09.009. Epub 2008 Dec 24. Adv Drug Deliv Rev. 2009. PMID: 19146895 Review.

8

Mechanistic studies of a cell-permeant peptide designed to enhance myosin light chain phosphorylation in polarized intestinal epithelia.

Almansour K, Taverner A, Eggleston IM, Mrsny RJ. Almansour K, et al. Among authors: mrsny rj. J Control Release. 2018 Jun 10;279:208-219. doi: 10.1016/j.jconrel.2018.03.033. Epub 2018 Mar 31. J Control Release. 2018. PMID: 29614254

9

Oral drug delivery research in Europe.

Mrsny RJ. Mrsny RJ. J Control Release. 2012 Jul 20;161(2):247-53. doi: 10.1016/j.jconrel.2012.01.017. Epub 2012 Feb 11. J Control Release. 2012. PMID: 22342473 Free article. Review.

10

Formulation and delivery issues for monoclonal antibody therapeutics.

Daugherty AL, Mrsny RJ. Daugherty AL, et al. Among authors: mrsny rj. Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):686-706. doi: 10.1016/j.addr.2006.03.011. Epub 2006 May 22. Adv Drug Deliv Rev. 2006. PMID: 16839640 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page